Ignite Creation Date:
2024-05-05 @ 11:28 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00045500
Status:
COMPLETED
Last Update Posted:
2015-04-30
First Post:
2002-09-06
Brief Title:
UCN-01 and Prednisone in Treating Patients With Solid Tumors or Lymphoma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma |
| Unspecified Adult Solid Tumor Protocol Specific |
Keywords:
| Name | View |
|---|---|
| splenic marginal zone lymphoma | View |
| anaplastic large cell lymphoma | View |
| angioimmunoblastic T-cell lymphoma | View |
| intraocular lymphoma | View |
| primary central nervous system non-Hodgkin lymphoma | View |
| recurrent adult Hodgkin lymphoma | View |
| recurrent adult T-cell leukemialymphoma | View |
| recurrent adult diffuse large cell lymphoma | View |
| recurrent adult diffuse mixed cell lymphoma | View |
| recurrent adult diffuse small cleaved cell lymphoma | View |
| recurrent adult immunoblastic large cell lymphoma | View |
| recurrent adult lymphoblastic lymphoma | View |
| recurrent cutaneous T-cell non-Hodgkin lymphoma | View |
| recurrent grade 1 follicular lymphoma | View |
| recurrent grade 2 follicular lymphoma | View |
| recurrent mantle cell lymphoma | View |
| unspecified adult solid tumor protocol specific | View |
| recurrent adult Burkitt lymphoma | View |
| recurrent grade 3 follicular lymphoma | View |
| recurrent marginal zone lymphoma | View |
| recurrent small lymphocytic lymphoma | View |
| extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue | View |
| nodal marginal zone B-cell lymphoma | View |